Cromolyn Sodium

ApprovedSmall molecule

UUniversity of California, San Francisco

Cromolyn Sodium is one of 88 small molecule programs targeting Erythema. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ErythemaActive, not recruiting

PneumoniaActive, not recruiting

Eosinophilic EsophagitisActive, not recruiting

Locally-Advanced Non-Small Cell Lung CancerNot yet recruiting

ErythemaPhase 1/Phase 2

Active, not recruiting

PneumoniaPhase 3

Active, not recruiting

Eosinophilic EsophagitisApproved

Active, not recruiting

Locally-Advanced Non-Small Cell Lung CancerPhase 1

Not yet recruiting

Competition

Competitive Landscape

547 competitors in Pneumonia

#DrugCompanyPhaseTrials

Cromolyn Sodium

UUniversity of California, San Francisco

Approved

1 2

Jakafi

Incyte

Preclinical

1 3

Primaquine

Sanofi

Preclinical

1 4

Virazole

CConrado Roberto Hoffmann Filho

Preclinical

2 5

Advil

KKenvue Brands

Preclinical

2 6

Primsol

CConrado Roberto Hoffmann Filho

Preclinical

2 7

Aciphex

Akero Therapeutics

Preclinical

1 8

Protonix

WWyeth-Lederle Vaccines

Preclinical

1 9

Alka-Seltzer

AAbbott

Preclinical

1 10

Tylenol

KKenvue Brands

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

Phase 1Not yet recruiting

Locally-Advanced Non-Small Cell Lung Cancer

NCT07675876

Q1 2028

Phase 2Recruiting

Treatment

NCT07142291

Clinical

Trials by Indication[1]

Treatment2 trials

Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)

Completed·PPulmotect, Inc.·Phase 1·NCT02566252·16 enrolled

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

Recruiting·PPhenoNet, Inc.·Phase 2·NCT07142291·105 enrolled

Aspiration1 trial

Cromolyn Detection of Silent Aspiration

Terminated·UUniversity of California, San Francisco·Phase 1·NCT01841307·16 enrolled

Pruritus1 trial

Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus

Completed·SShiraz University of Medical Sciences·Phase 2·NCT00745199·62 enrolled

Pneumonia1 trial

Cromolyn Sodium for Treatment of COVID-19 Pneumonia

Terminated·TTexas Tech University Health Sciences Center, El Paso·Phase 3·NCT05077917·22 enrolled

Pelvic Pain1 trial

Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction

Completed·NNorthwestern University·Phase 1·NCT03167216·20 enrolled

3 more indications

Eosinophilic Esophagitis1 trial

Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis

Completed·UUniversity of Tennessee·Phase 4·NCT02371941·16 enrolled

Erythema1 trial

An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema

Completed·UUniversity of California, San Diego·Phase 1/2·NCT01933464·10 enrolled

Locally-Advanced Non-Small Cell Lung Cancer1 trial

An Open-Label Pilot Study Evaluating the Safety, Feasibility, and Preliminary Clinical Activity of Inhaled Cromolyn Sodium in Participants With Locally Advanced Lung Cancer

Not yet recruiting·CCarcinex Inc·Phase 1·NCT07675876·10 enrolled

Sources

References

[1]
ClinicalTrials.gov — 9 trial records for Cromolyn Sodium. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Cromolyn Sodium compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Cromolyn Sodium. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of California, San Francisco company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: UUniversity of California, San Francisco

Cromolyn Sodium

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Q1 2028

Trials by Indication[1]

Treatment2 trials

Aspiration1 trial

Pruritus1 trial

Pneumonia1 trial

Pelvic Pain1 trial

Eosinophilic Esophagitis1 trial

Erythema1 trial

Locally-Advanced Non-Small Cell Lung Cancer1 trial

References

Drug Info

Quick Facts

Related News